SORRENTO THERAPEUTICS
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch SRNE and buy or sell other stocks, ETFs, and their options commission-free!About SRNE
Sorrento Therapeutics, Inc. engages in the research, development, and manufacture of biopharmaceutical products. It operates through the Sorrento Therapeutics and Scilex segments.
CEOHenry H. Ji, PhD
CEOHenry H. Ji, PhD
Employees—
Employees—
HeadquartersSan Diego, California
HeadquartersSan Diego, California
Founded1989
Founded1989
Employees—
Employees—
SRNE Key Statistics
Market cap1.54M
Market cap1.54M
Price-Earnings ratio—
Price-Earnings ratio—
Dividend yield—
Dividend yield—
Average volume548.56K
Average volume548.56K
High today$0.0032
High today$0.0032
Low today$0.0025
Low today$0.0025
Open price$0.0025
Open price$0.0025
Volume22.51K
Volume22.51K
52 Week high$0.0985
52 Week high$0.0985
52 Week low$0.0001
52 Week low$0.0001
Stock Snapshot
SORRENTO THERAPEUTICS(SRNE) stock is priced at $0.00, giving the company a market capitalization of 1.54M.
On 2026-01-09, SORRENTO THERAPEUTICS(SRNE) stock moved within a range of $0.00 to $0.00. With shares now at $0.00, the stock is trading +24.0% above its intraday low and -3.1% below the session's peak.
Trading volume for SORRENTO THERAPEUTICS(SRNE) stock has reached 22.51K, versus its average volume of 548.56K.
The stock's 52-week range extends from a low of $0.00 to a high of $0.10.
The stock's 52-week range extends from a low of $0.00 to a high of $0.10.
People also own
Based on the portfolios of people who own SRNE. This list is generated using Robinhood data, and it’s not a recommendation.